Thank you for your inquiry regarding CMS347v7 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease. You are correct. Repatha is currently not listed as a medication for numerator inclusion nor denominator exclusion/exception this measure. Per the measure guidance, only statin therapy meets the measure numerator criteria, not other cholesterol lowering medications. Patients who meet the denominator criteria for inclusion, but are not prescribed or using statin therapy, will not meet performance for this measure unless they have an allowable denominator exception. Available drugs and their usage monitored on a regular basis for potential inclusion in future versions of this measure.

Hello, we have a provider question. In the event a patient is being prescribed Repatha, our provider states that this would eliminate the requirement of a statin for the patient. From the specifications, we can see that this medication Repatha or this pharmaceutical subclass Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors, is not listed as a medication for numerator inclusion nor denominator exclusion/exception this measure. In the event a patient is on this medication, the provider is stating they would not prescribe additional statin therapy. Asking if you can confirm we have the correct understanding of the current specifications and if there is any more information about this medication that we can relay back to our providers to improve on this measure. Thank you!